Bonnie L. Bassler, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 760 shares at $750.00 ($570K) on 2025-11-20, disclosed to the SEC on 2025-11-24.
Scheduled sale ($570k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2024-08-05 | $843K | — | Filing → |
| REGN | SELL | 2024-06-25 | $803K | — | Filing → |
| REGN | SELL | 2024-06-07 | $836K | — | Filing → |